BeyondSpring Inc. Unrealized Gain (Loss) on Investments
BeyondSpring Inc. (BYSI) reported Unrealized Gain (Loss) on Investments of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-03-25
- BeyondSpring Inc. unrealized gain (loss) on investments for the quarter ending 2025-12-31 was $0.00.
- BeyondSpring Inc. unrealized gain (loss) on investments for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- BeyondSpring Inc. unrealized gain (loss) on investments for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- BeyondSpring Inc. unrealized gain (loss) on investments for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- BeyondSpring Inc. unrealized gain (loss) on investments for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- BeyondSpring Inc. unrealized gain (loss) on investments for fiscal 2024 was $3.00K, a 25.00% decline from fiscal 2023.
- BeyondSpring Inc. unrealized gain (loss) on investments for fiscal 2023 was $4.00K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 derived: sum of 3 quarters · filed 2026-03-25 | $0.00 10-K · filed 2026-03-25 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | -$42.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 | -$42.00K derived: sum of 3 quarters · filed 2026-03-25 | -$19.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-12 | -$42.00K derived: sum of 2 quarters · filed 2026-03-25 | -$19.00K derived: sum of 3 quarters · filed 2026-03-25 | -$1.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-12-31 | -$42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$19.00K derived: sum of 2 quarters · filed 2026-03-25 | -$1.00K derived: sum of 3 quarters · filed 2026-03-25 | $3.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $41.00K derived: sum of 2 quarters · filed 2025-11-12 | $45.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $22.00K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $4.00K 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $4.00K 10-K · filed 2025-03-27 | |||
| 2022-12-31 | $19.00K 20-F · filed 2023-04-18 | |||
| 2021-12-31 | $39.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $144.00K 20-F · filed 2023-04-18 | ||
| 2021-09-30 | $105.00K 6-K · filed 2021-12-30 | |||
| 2020-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $0.00 20-F · filed 2023-04-18 | ||
| 2020-09-30 | $0.00 6-K · filed 2021-12-30 | |||
| 2019-12-31 | $0.00 20-F · filed 2022-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |